Clinical Research: Phase 1 - Phase 4

A Vast Unmet Need: Challenges in Alzheimer’s Disease Clinical Trials

Despite intensive research, nearly 15 years have passed since the last new Alzheimer’s disease medication was approved. For those living with Alzheimer’s disease, progress toward understanding and treating this most prevalent form of dementia has been frustratingly slow. Understanding the obstacles inherent in Alzheimer’s clinical trials, from high screen failure rates to lengthy trial durations that are demanding for both patients and caregivers, can help sponsors plan for – and overcome – these challenges.